搜索筛选:
搜索耗时1.3741秒,为你在为你在102,285,761篇论文里面共找到 3 篇相符的论文内容
类      型:
[会议论文] 作者:Xiaojing Yan,Lingxi Chen,Liangbo Sun,Tao Li,Fengtian He,Jiqin Lian, 来源:中国生物化学与分子生物学会第十二届会员代表大会暨2018年全国学术会议 年份:2018
Sorafenib is the first-line drug for advanced hepatocellular carcinoma(HCC),but the clinical response to sorafenib is seriously limited by drug resistance.In this study,we investigated the molecular m...
[期刊论文] 作者:ZHANG Lingxi,CHEN Yifan,XU Haixing,BAO Yun,YAN Xiumei,LI Yixuan,LI Yiping, 来源:武汉理工大学学报(材料科学版)(英文版) 年份:2016
[会议论文] 作者:Xiaojing Yan,Peng Xie,Lingxi Chen,Liangbo Sun,Tao Li,YueTing Zhang,Hanxi Xiao,Fengtian He,Jiqin Lian, 来源:中国生物化学与分子生物学会2019年全国学术会议 年份:2019
Liver cancer is one of the most common malignancies with high recurrence rate.Besides radiotherapy and surgery,chemotherapy also plays an important role in the treatment of liver cancer....
相关搜索: